Language:
  
[Sign in] [Register]   

EIAab logo

EIAab news detail, please contact eiaab@eiaab.com if you have any questions about online orders and payment.
Targeting Apoptosis, Advanced Glycation End Products and Transforming Growth Factor-β1 by Biguanides and Resveratrol to Ameliorate Experimentally- …
Update time:2016-07-28 23:58:00   【 Font: Large  Medium Small

Abstract

Background: Diabetic nephropathy is one of the complications of diabetes caused by angiopathy of capillaries in the renalglomeruli. Its mechanisms may include glycosylation of renal proteins, abnormal intrarenal hemodynamics and hypertension. Resveratrol is a natural compound found in grapes and red wine that offers protective effects against many cardiovascular diseases and cancer. Metformin is a biguanide that is considered as the first-line drug for treatment of type 2 diabetes.
Objective: To study the effect of each of resveratrol and metformin alone and in combination on streptozotocin (STZ)-induced diabetic nephropathy.
Methods: 100 male Wistar rats were divided into 5 equal groups: Control untreated group, STZ group, STZ + Metformin group, STZ + Resveratrol group, and STZ + Resveratrol + Metformin group. Kidney weight/body weight ratio, serum fasting glucose, glycosylated Hb, blood urea, serum creatinine and creatinine clearance were determined. A part of the kidney was homogenized for determination of tissue tumor necrosis factor alpha (TNF-α), transforming growth factor beta 1 (TGF-β1), nitric oxide (NO), reduced glutathione (GSH), advanced glycation end products (AGEs) and caspase-3 activity. The other part was subjected to histopathological examination.
Results: Both resveratrol and metformin alone and in combination induced significant increase in creatinine clearance, tissue GSH and tissue caspase-3 activity with significant decrease in kidney weight/body weight ratio, serum fasting glucose, glycosylated Hb, blood urea, serum creatinine, tissue TNF-α, TGF-β1, NO and AGEs and alleviated the histopathological changes compared to the group that received STZ alone.
Conclusion: Resveratrol/metformin combination had a protective effect on experimentally-induced diabetic nephropathy in rats.

 

Cited products
Source:Journal of Drug      by Kabel A M, Omar M S, Borg H M.
Hot Genes
ALCAM ACE KSR2 ASPRO C19orf80 Gdf5 Trap1a Atf2
Top Searches
Ubiquitin ELISA Ubiquitin-protein ligase metalloproteinase Asprosin TRAP1A Tumor necrosis vitamin d
Why choose EIAAB
Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
Further Information
About us Protein center Bank account Distributors Terms & Conditions Career eiaab.cn

Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

Twitter